Business Context and Reporting Period
Company: James Hardie Industries plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of June 2020 (Filed June 8, 2020)
Principal Executive Offices: Dublin, Ireland
This filing serves as a procedural report containing forward-looking statements and an exhibit index. It does not contain a full set of financial results for the period.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on legal disclosures and risk factors rather than quantitative financial performance data.
Material Changes
No material financial changes or comparative period data are presented in this specific filing. The document references the impact of the COVID-19 public health crisis as a significant factor affecting the business but does not quantify the impact in this text.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing includes extensive disclosures regarding future expectations, including:
- Future performance, operational results, and financial condition.
- Plans for capital expenditure, plant closures, and credit facility renewals.
- Dividend payments and share buy-backs.
- Contributions to the Asbestos Injuries Compensation Fund (AICF).
Key Risks and Contingencies:
- COVID-19: Significant negative impact expected on sales, operations, and financial condition.
- Asbestos Liability: Risks related to prior asbestos product manufacture, AICF contributions, and potential shortfalls.
- Market Conditions: Dependence on housing markets, new home construction, and consumer confidence.
- Legal and Regulatory: Exposure to product liability, environmental, and competition law matters.
- Operational: Integration of Fermacell, supply chain costs, and currency exchange risks.
Investor Verification Checklist
- Verify the specific financial impact of COVID-19 in the company's most recent quarterly or annual report (Form 20-F or 40-F), as this 6-K does not quantify the loss.
- Review the "Risk Factors" section of the Form 20-F filed on May 19, 2020, for detailed legal and operational risks.
- Confirm the status of the Asbestos Injuries Compensation Fund (AICF) and any recent changes to contribution estimates.
- Check for updates on the integration of the Fermacell acquisition.
- Monitor credit facility terms and covenants given the economic uncertainty.